CD8A and neoplasm: To elucidate which immune cells contributed to the ICB-enhanced tumor-reactivity, we performed killing assays with isolated immune subsets: CD4, CD8, γδT, NK cells, and full peripheral blood mononuclear cells (PBMC) lacking each of these populations (Figure S8G).